Your browser doesn't support javascript.
loading
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
Riou, Catherine; Bhiman, Jinal N; Ganga, Yashica; Sawry, Shobna; Ayres, Frances; Baguma, Richard; Balla, Sashkia R; Benede, Ntombi; Bernstein, Mallory; Besethi, Asiphe S; Cele, Sandile; Crowther, Carol; Dhar, Mrinmayee; Geyer, Sohair; Gill, Katherine; Grifoni, Alba; Hermanus, Tandile; Kaldine, Haajira; Keeton, Roanne S; Kgagudi, Prudence; Khan, Khadija; Lazarus, Erica; Roux, Jean Le; Lustig, Gila; Madzivhandila, Mashudu; Magugu, Siyabulela Fj; Makhado, Zanele; Manamela, Nelia P; Mkhize, Qiniso; Mosala, Paballo; Motlou, Thopisang P; Mutavhatsindi, Hygon; Mzindle, Nonkululeko B; Nana, Anusha; Nesamari, Rofhiwa; Ngomti, Amkele; Nkayi, Anathi A; Nkosi, Thandeka P; Omondi, Millicent A; Panchia, Ravindre; Patel, Faeezah; Sette, Alessandro; Singh, Upasna; van Graan, Strauss; Venter, Elizabeth M; Walters, Avril; Moyo-Gwete, Thandeka; Richardson, Simone I; Garrett, Nigel; Rees, Helen.
Afiliación
  • Riou C; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Observatory, South Africa.
  • Bhiman JN; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Observatory, South Africa.
  • Ganga Y; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Sawry S; Center for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Ayres F; Africa Health Research Institute, Durban, South Africa.
  • Baguma R; Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Balla SR; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Benede N; Center for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Bernstein M; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Observatory, South Africa.
  • Besethi AS; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Cele S; Center for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Crowther C; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Observatory, South Africa.
  • Dhar M; Africa Health Research Institute, Durban, South Africa.
  • Geyer S; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Observatory, South Africa.
  • Gill K; Africa Health Research Institute, Durban, South Africa.
  • Grifoni A; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Hermanus T; Center for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Kaldine H; Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Keeton RS; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Observatory, South Africa.
  • Kgagudi P; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
  • Khan K; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Lazarus E; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Roux JL; Center for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Lustig G; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Madzivhandila M; Center for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Magugu SF; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Observatory, South Africa.
  • Makhado Z; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Manamela NP; Center for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Mkhize Q; Africa Health Research Institute, Durban, South Africa.
  • Mosala P; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Motlou TP; Perinatal HIV Research Unit, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa.
  • Mutavhatsindi H; Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Mzindle NB; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.
  • Nana A; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Nesamari R; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Observatory, South Africa.
  • Ngomti A; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Nkayi AA; Center for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Nkosi TP; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Omondi MA; Center for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Panchia R; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Patel F; Center for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Sette A; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Observatory, South Africa.
  • Singh U; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • van Graan S; Center for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.
  • Venter EM; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Observatory, South Africa.
  • Walters A; SA MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
  • Moyo-Gwete T; Perinatal HIV Research Unit, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa.
  • Richardson SI; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Observatory, South Africa.
  • Garrett N; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Observatory, South Africa.
  • Rees H; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Observatory, South Africa.
medRxiv ; 2023 Nov 20.
Article en En | MEDLINE | ID: mdl-38045321

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: MedRxiv Año: 2023 Tipo del documento: Article País de afiliación: Sudáfrica

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: MedRxiv Año: 2023 Tipo del documento: Article País de afiliación: Sudáfrica